{"id":"NCT02034513","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes","officialTitle":"A Randomised, Double Blind, Cross-over Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (SWITCH 1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-05","primaryCompletion":"2016-01-11","completion":"2016-01-11","firstPosted":"2014-01-13","resultsPosted":"2017-05-15","lastUpdate":"2019-01-02"},"enrollment":501,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"IDeg OD + IAsp followed by IGlar OD + IAsp","type":"EXPERIMENTAL"},{"label":"IGlar OD + IAsp followed by IDeg OD + IAsp","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to compare the safety and efficacy of insulin degludec (IDeg) and insulin glargine (IGlar), both with insulin aspart (IAsp) as mealtime insulin in subjects with type 1 diabetes.","primaryOutcome":{"measure":"Number of Treatment Emergent Severe or BG (Blood Glucose) Confirmed Symptomatic Hypoglycaemic Episodes During the Maintenance Period","timeFrame":"A 16-week treatment period.","effectByArm":[{"arm":"Insulin Degludec (IDeg)","deltaMin":2772,"sd":null},{"arm":"Insulin Glargine (IGlar)","deltaMin":3126,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":99,"countries":["United States","Poland","Puerto Rico"]},"refs":{"pmids":["28672316","30097995","30362250"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":454},"commonTop":["Nasopharyngitis","Upper respiratory tract infection"]}}